Peripheral blood lymphocytes subtypes as new predictors for neoadjuvant therapy efficacy in breast cancer

Peripheral blood lymphocytes subtypes as new predictors for neoadjuvant therapy efficacy in breast cancer

Abstract Background Host immunity plays an important role in tumor development and treatment. Tumor‐infiltrating lymphocytes (TILs) have been proven to predict the efficacy of neoadjuvant therapy (NAT) in breast cancer (BC) patients, but their application is limited due to various reasons. This stud...

Full description

Bibliographic Details
Main Authors: Jikun Feng, Jiarong Yi, Xiazi Zouxu, Jianxia Li, Zhenchong Xiong, Xinjian Huang, Wenjing Zhong, Weiling Huang, Feng Ye, Xi Wang
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:Cancer Medicine
Subjects:
breast cancer
independent predictors
neoadjuvant therapy
PBLs subtypes
Online Access:https://doi.org/10.1002/cam4.4666

Internet

https://doi.org/10.1002/cam4.4666

Similar Items